Results 131 to 140 of about 12,265 (153)

The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery

Drug Delivery, 2022
Aaron Hieb, Tammy Tam, Lori Grace
exaly  

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation

Ophthalmology and Therapy, 2021
Dhanashree Ratra
exaly  

Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study

Acta Ophthalmologica, 2022
Johanna Madeleine Pfeil, Wolf Lagrèze, Andreas Stahl   +2 more
exaly  

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Lancet, The, 2019
Neil Marlow, Domenico Lepore, Andreas Stahl   +2 more
exaly  

Persisent ocular hypertension following intravitreal ranibizumab

Graefe's Archive for Clinical and Experimental Ophthalmology, 2008
Sophie Bakri, Colin Archibald Mccannel, Darius M Moshfeghi   +2 more
exaly  

Ranibizumab

Reactions Weekly, 2010
openaire   +1 more source

Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis

Photodiagnosis and Photodynamic Therapy, 2018
Yu Gu
exaly  

Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology, 2018
Yusuf Koçluk, Emine Alyamac Sukgen, Koçluk Yusuf   +2 more
exaly  

Ranibizumab

Reactions Weekly, 2018
openaire   +2 more sources

Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity

Ophthalmology, 2017
Ping Fei, Yu Xu, Jie Peng
exaly